Oncolinx

Oncolinx is a company developing antibody-drug conjugates (ADCs). They carry an azonafide cytotoxin attached to an antibody to tumor cells, avoiding side effects associated with traditional forms of chemotherapy. It induces cancer cell death and activates the immune system through immunogenic cell death (ICD).